- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06192498
Effects of Virtual Reality Glasses, Kaleidoscope and Distraction Cards on Pain and Anxiety During Blood Draw in Children
Comparison of the Effectiveness of Virtual Reality Glasses, Kaleidoscope and Distraction Cards in Reducing Pain and Anxiety During Blood Draw in Children: A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
n the literature, it is stated that nurses should use pharmacological and non-pharmacological methods in pain and anxiety management in painful procedures. Evidence-based studies are needed to show the effectiveness of non-pharmacological methods in reducing pain during invasive procedures and to investigate the effects of easy-to-apply methods on pain. In light of this information, this study aimed to compare the effect of distraction by using Virtual Reality Glasses, Kaleidoscope and Distraction Cards in reducing pain and anxiety during blood draw in children.
This study is a prospective, randomized and controlled trial. Children aged 7 to 11 years who required blood draw were divided into three groups; Virtual Reality Glasses, Kaleidoscope, Distraction Cards and Control. Data were obtained through face-to-face interviews with the children, their parents, and the observer before and after the procedure. The children's pain levels were assessed and reported by the parents and observers and the children themselves who self-reported using Wong-Baker FACES. The children's anxiety levels were also assessed using the Children's Fear Scale.
The study population consisted of children aged 7 to 11 years who presented to the children's blood draw room of the hospital.
Sample of the study consisted of a total of 400 children who met the sample selection criteria and were selected via randomization method.
Children were randomized into three groups: Virtual Reality Glasses group (n= 100), Kaleidoscope group (n= 100), Distraction Cards group (n= 100) and Control group (n= 100).
Data were collected using the Interview and Observation Form, Wong-Baker FACES Pain Rating Scale, Children's Fear Scale.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Karaman, Turkey
- Karaman education and research hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children between the ages of 7-11,
- Volunteering of the child and parent to participate in the study,
- Blood draw for routine control purposes,
- Blood draw should be done by the same nurse,
- The needle on which blood draw will be performed must be of the same thickness.
Exclusion Criteria:
- The child has any acute or chronic disease,
- The child has a mental disability, vision, speech or communication problems,
- The parent has hearing, vision or verbal communication difficulties,
- The child used analgesics in the last 6 hours,
- Infection, disruption of skin integrity and rash in the area where the application will be made,
- Exclusion criteria were that the parent or child wanted to leave the study at any point.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Glasses Group
Virtual Reality(VR) Glasses were introduced to the children pre-procedure.
The children were made to watch a video with VR glasses before starting the application and it continued until the end of the Blood Draw procedure.
|
Virtual Reality(VR) Glasses were introduced to the children pre-procedure.
The children were made to watch a video with VR glasses before starting the application and it continued until the end of the Blood Draw procedure.
|
|
Experimental: Kaleidoscope Group
Kaleidoscope were introduced to the children pre-procedure.
The children were made to watch Kaleidoscope before starting the application and it continued until the end of the Blood Draw procedure.
|
Kaleidoscope were introduced to the children pre-procedure.
The children were made to watch Kaleidoscope before starting the application and it continued until the end of the Blood Draw procedure.
|
|
Experimental: Distraction Cards Group
Distraction Cards were introduced to the children pre-procedure.
The children were made to apply Distraction Cards before starting the application and it continued until the end of the Blood Draw procedure.
|
Distraction Cards were introduced to the children pre-procedure.
The children were made to apply Distraction Cards before starting the application and it continued until the end of the Blood Draw procedure.
|
|
No Intervention: Control Group
In this group, children received routine blood draw procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wong-Baker FACES Pain Rating Scale
Time Frame: Through painful procedure completion, an average of 10 minutes
|
In the study, pain level evaluations, the children's self-evaluations, parents' evaluations and the researcher's evaluations were carried out using the WB-FACES scale.
This scale was developed by Donna Wong and Connie Morain Baker in 1988.
The scale is graded between 0-10 points.
A smiling face on the far left symbolizes "no pain" (0 very happy/no pain) and the pain increases from left to right.
On the other hand, a crying face on the far right symbolizes "unbearable pain" (10 'hurts worst').
As the numbers increase in this scoring system, facial expressions also change referring to an increase in pain levels.
|
Through painful procedure completion, an average of 10 minutes
|
|
Children's Fear Scale
Time Frame: Through painful procedure completion, an average of 10 minutes
|
CFS is used for measuring the child's anxiety level.
CFS is a scale which makes an evaluation from 0 to 4 consisting of five facial expressions drawn to show expressions that vary from neutral expression (0=no anxiety) to scared face (4=severe anxiety).
|
Through painful procedure completion, an average of 10 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Selda Ateş Beşirik, PhD., Burdur Mehmet Akif Ersoy University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-2018/22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Virtual Reality Glasses
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
Yuzuncu Yil UniversityCompletedHyperthyroidism | Virtual RealityTurkey (Türkiye)
-
Ankara Yildirim Beyazıt UniversityCompletedVirtual Reality | Education | Bariatric Surgery | NursingTurkey (Türkiye)
-
Biruni UniversityCompleted
-
Saglik Bilimleri UniversitesiCompletedPain | Anxiety | Gastro-Intestinal DisorderTurkey
-
Necmettin Erbakan UniversityHealth Institutes of TurkeyCompleted
-
Özlem ÇiçekIzmir Bakircay UniversityCompletedEpisiotomy WoundTurkey
-
Istanbul Sabahattin Zaim UniversityCompleted
-
Esra DOĞAN YILMAZ, RN, MScCompletedThe Effects of Virtual Reality Glasses on Vital Signs and Anxiety in Patients Undergoing ColonoscopyAnxiety | Colonoscopy | Vital SignsTurkey
-
Saglik Bilimleri UniversitesiUnknown